Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Dr K E Donahue
Correspondence to: Dr K E Donahue, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; firstname.lastname@example.org
In adults with rheumatoid arthritis (RA), what are the relative benefits and harms of various disease-modifying antirheumatic drugs (DMARDs)?
Studies selected compared different DMARDs in adults with RA. Outcomes were clinical response, radiographic progression, functional capacity, quality of life, and adverse events.
5 databases (to September 2007); reference lists; and drug companies were searched for head-to-head, randomised, controlled trials (RCTs) and prospective cohort studies, published in English with ⩾100 patients and ⩾12 weeks of follow-up. 143 articles on 101 studies met the selection criteria. …
Source of funding: Agency for Healthcare Research and Quality.